Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human TIMP1 ELISA Kit (AC3684)
Cat.#: ASET-2273
Specifications
Description Human TIMP1 ELISA Kit allows for the in vitro quantitative determination of human TIMP1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2023 Human PAX8 ELISA Kit (AC3434) Quantitative inquiry ASET-2296 Human ATG9A ELISA Kit (AC3707) Quantitative inquiry ASET-1520 Rat Neuroligin 3 ELISA Kit (AC2931) Quantitative inquiry ASET-1624 Human NOTCH3 ELISA Kit (AC3035) Quantitative inquiry ASET-1596 Human PRAS40 ELISA Kit (AC3007) Quantitative inquiry ASET-1964 Human Prol1 ELISA Kit (AC3375) Quantitative inquiry ASET-1035 Mouse Adiponectin ELISA Kit (AC2446) Quantitative inquiry ASET-1898 Monkey beta Nerve Growth Factor ELISA Kit (AC3309) Quantitative inquiry ASET-1422 Mouse Ataxin 1 ELISA Kit (AC2833) Quantitative inquiry ASET-1332 Human Somatostatin Receptor 2 ELISA Kit (AC2743) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket